Holen Sie sich die Stockscreener-App
839.87
2.44%
20.02
Handel nachbörslich:
839.95
0.08
+0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
2 Beaten-Down Stocks Primed for a Comeback - The Motley Fool
Precision Trading with Eli Lilly And Company (LLY) Risk Zones - news.stocktradersdaily.com
Jim Cramer Highlights Eli Lilly’s Drug Potential Beyond Diabetes and Obesity - MSN
Eli Lilly’s Stock Soars Amid Promising Trials - TipRanks
Alphabet, Micron, Block, Costco, Eli Lilly: Major Stock Moves Unveiled! - TipRanks
Eli Lilly (LLY) Laps the Stock Market: Here's Why - sharewise.com
Major Stakeholder Offloads Millions in Eli Lilly Stock! - TipRanks
How Eli Lilly And Company (LLY) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Eli Lilly (LLY): Exploring the Latest Valuation as Shares Hold Steady - simplywall.st
Stock Quote & Chart - Eli Lilly and Company
High-profile biotech visitors praise Houston's workforce, warn of 'valley of death' for technology - The Business Journals
Is Eli Lilly Stock A Buy After Surging On Trump's Drug-Pricing Plans? - Investor's Business Daily
Why Eli Lilly (LLY) Shares Are Rising Today - GuruFocus
Why Shares of Eli Lilly Soared This Week - The Motley Fool
Morgan Stanley Adjusts Price Target on Eli Lilly (LLY) | LLY Sto - GuruFocus
Eli Lilly and Company Stock (LLY) Opinions on Drug Pricing Initiative - Quiver Quantitative
Eli Lilly Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) - Benzinga
Analyst Explains Why Eli Lilly (LLY) GLP-1 Advantage is Decreasing - Yahoo
Morgan Stanley Trims Price Target on Eli Lilly to $1,023 From $1,028, Keeps Overweight Rating - MarketScreener
Eli Lilly and Company (LLY) Gets Upgraded to a Buy by CFRA - MSN
Eli Lilly (LLY): Does Its Recent Strength Signal More Valuation Upside for Investors? - simplywall.st
HSBC Sticks to Its Hold Rating for Eli Lilly & Co (LLY) - The Globe and Mail
Eli Lilly And Its Competitors Pop On The Pfizer News - Real Investment Advice
Why Eli Lilly Is The Lion's Share Of My Portfolio - Seeking Alpha
Major Stock Moves: Lilly Endowment Inc’s Massive Eli Lilly & Co Sell-Off - TipRanks
Eli Lilly and Co(LLY.US) 10% Shareholder Sells US$284.65 Million in Common Stock - 富途牛牛
Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma - Stocktwits
Sek Kathiresan: Thrilled to Join Eli Lilly and Co. as Senior Vice President - Oncodaily
Eli Lilly’s Volenrelaxin Study Withdrawn: Implications for Investors - TipRanks
Eli Lilly’s Groundbreaking Study on STX-478: A New Hope for Advanced Solid Tumors - TipRanks
Novo’s Wegovy and Lilly’s Zepbound recommended in Europe as first-line obesity treatments - Seeking Alpha
HSBC sees Novo Nordisk doing well in race against Eli Lilly - medwatch.com
Houston pharmacy Empower seeks dismissal of Eli Lilly lawsuit over drug compounding rights - The Business Journals
Eli Lilly (LLY) Rated Outperform With Strong GLP-1 Prospects - MSN
Major Shareholder Sells Millions in Eli Lilly Stock! - TipRanks
Eli Lilly's Drug Suit Slammed As 'Anti-Competitive' Move - Law360
Eli Lilly Stock Surges Amid FDA Wins and Manufacturing Expansion - Azat TV
As Drug Discovery Tackles More Difficult Challenges, Lilly Wants To Help - insights.citeline.com
Why Is Eli Lilly (LLY) Stock Rocketing Higher Today - The Globe and Mail
Eli Lilly Shares Are Trading Higher Wednesday: What's Going On? - Benzinga
Eli Lilly Stock Surges on Obesity-Drug Boom – Is $1,000 Next? - ts2.tech
Eli Lilly’s Skyrocketing Stock: Buy or Wait? - timothysykes.com
Eli Lilly and Company (LLY) Expands Global Reach with Orforglipron Launch Plans in India - MSN
Eli Lilly, Merck Lead Market Cap Stock Movers on Wednesday - Investing.com
Eli Lilly’s Soaring Momentum: What’s Next? - StocksToTrade
HSBC Lifts Eli Lilly's Price Target to $800 From $700 - MarketScreener
What sent Eli Lilly stock soaring 8% in one day - Rolling Out
How Novo Nordisk Gave Up Its Weight-Loss Gains - Bloomberg.com
Why Eli Lilly’s Stock is Climbing Higher - TipRanks
Lilly Gets Partial Win in Suit Over FDA’s Biologic Determination - Bloomberg Law News
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away - Benzinga
Eli Lilly, Merck Surge Among Wednesday’s Market Cap Stock Movers - Investing.com
GLP-1s: Lilly, Novo Gallop In India, Generic Firms Gear ‘To Finish The Race’ - insights.citeline.com
Eli Lilly and Pasadena-Based Alexandria Launch New Biotech Hub in San Diego’s Torrey Pines Alexandria Real Estate Equities, Inc., headquartered in downtown Pasadena, has partnered with Eli Lilly and Company to open a new Lilly Gateway Labs facility a - facebook.com
Lilly Announces Agreement to Acquire Dermira - Eli Lilly and Company
Eli Lilly and Company (LLY) Halts Experimental Study of Muscle-Sparing Obesity Drug - Yahoo Finance
Eli Lilly and Company (LLY) Opens a New Lilly Gateway Labs Innovation Hub in San Diego - Yahoo Finance
LLY Stock Quote Price and Forecast - CNN
Eli Lilly in discussions with White House for TrumpRx dealreport - Seeking Alpha
Why Are Eli Lilly (LLY) Shares Soaring Today - The Globe and Mail
1.43%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):